Sasaki S - Search Results

1

Complication of coronavirus disease 2019 during remission induction therapy against anti-MDA5 antibody-positive dermatomyositis.

Kogami M, Suzuki S, Nanjo Y, Ikeda K, Tamura N, Sasaki S, Morimoto S. Kogami M, et al. Among authors: sasaki s. Rheumatol Adv Pract. 2020 Nov 17;4(2):rkaa068. doi: 10.1093/rap/rkaa068. eCollection 2020. Rheumatol Adv Pract. 2020. PMID: 33336141 Free PMC article. No abstract available.

2

Multiple Types of Taste Disorders among Patients with COVID-19.

Nanjo Y, Okuma T, Kuroda Y, Hayakawa E, Shibayama K, Akimoto T, Murashima R, Kanamori K, Tsutsumi T, Suzuki Y, Namba Y, Makino F, Nagashima O, Sasaki S, Takahashi K. Nanjo Y, et al. Among authors: sasaki s. Intern Med. 2022 Jul 15;61(14):2127-2134. doi: 10.2169/internalmedicine.9065-21. Epub 2022 May 7. Intern Med. 2022. PMID: 35527025 Free PMC article.

3

Disseminated non-tuberculous mycobacterial infection caused by anti-interferon-γ autoantibodies in a patient of very advanced age.

Yamada T, Iwakami SI, Hara SAM, Iwakami N, Nakamura A, Suzuki Y, Sasaki SI, Takahashi K. Yamada T, et al. Geriatr Gerontol Int. 2018 Jul;18(7):1132-1133. doi: 10.1111/ggi.13313. Geriatr Gerontol Int. 2018. PMID: 30133967 No abstract available.

4

CT Guided Needle Biopsy of Peripheral Lesions-Lesion Characteristics That May Increase the Diagnostic Yield and Reduce the Complication Rate.

Tajima M, Togo S, Ko R, Koinuma Y, Sumiyoshi I, Torasawa M, Kikuchi N, Shiraishi A, Sasaki S, Kyogoku S, Kuwatsuru R, Takahashi K. Tajima M, et al. Among authors: sasaki s. J Clin Med. 2021 May 9;10(9):2031. doi: 10.3390/jcm10092031. J Clin Med. 2021. PMID: 34065147 Free PMC article.

5

Successful resection of dermatomyositis associated with thymic carcinoma: report of a case.

Takahashi F, Tsuta K, Nagaoka T, Miyamoto H, Saito Y, Amano H, Uchida K, Morio Y, Shimizu K, Sasaki S, Tominaga S, Uekusa T, Izumi H, Anami Y, Matsuno Y, Takahashi K, Fukuchi Y. Takahashi F, et al. Among authors: sasaki s. Surg Today. 2008;38(3):245-8. doi: 10.1007/s00595-007-3601-x. Epub 2008 Feb 29. Surg Today. 2008. PMID: 18306999

6

Management of skin sarcoidosis with minocycline monotherapy.

Sasaki S, Kato M, Nakamura K, Namba Y, Nagashima O, Takahashi K. Sasaki S, et al. Respirol Case Rep. 2019 Mar 13;7(4):e00413. doi: 10.1002/rcr2.413. eCollection 2019 May. Respirol Case Rep. 2019. PMID: 30911395 Free PMC article.

7

Author Correction: Gastrointestinal adverse effects of nintedanib and the associated risk factors in patients with idiopathic pulmonary fibrosis.

Kato M, Sasaki S, Nakamura T, Kurokawa K, Yamada T, Ochi Y, Ihara H, Takahashi F, Takahashi K. Kato M, et al. Among authors: sasaki s. Sci Rep. 2020 Jul 16;10(1):12080. doi: 10.1038/s41598-020-69088-7. Sci Rep. 2020. PMID: 32669649 Free PMC article.

8

Clinical Significance of Continuable Treatment with Nintedanib Over 12 Months for Idiopathic Pulmonary Fibrosis in a Real-World Setting.

Kato M, Sasaki S, Tateyama M, Arai Y, Motomura H, Sumiyoshi I, Ochi Y, Watanabe J, Ihara H, Togo S, Takahashi K. Kato M, et al. Among authors: sasaki s. Drug Des Devel Ther. 2021 Jan 18;15:223-230. doi: 10.2147/DDDT.S284819. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 33500614 Free PMC article.

9

Gastrointestinal adverse effects of nintedanib and the associated risk factors in patients with idiopathic pulmonary fibrosis.

Kato M, Sasaki S, Nakamura T, Kurokawa K, Yamada T, Ochi Y, Ihara H, Takahashi F, Takahashi K. Kato M, et al. Among authors: sasaki s. Sci Rep. 2019 Aug 19;9(1):12062. doi: 10.1038/s41598-019-48593-4. Sci Rep. 2019. PMID: 31427707 Free PMC article.

10

Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial.

Sakamoto S, Kataoka K, Kondoh Y, Kato M, Okamoto M, Mukae H, Bando M, Suda T, Yatera K, Tanino Y, Kishaba T, Hattori N, Taguchi Y, Saito T, Nishioka Y, Kuwano K, Kishi K, Inase N, Sasaki S, Takizawa H, Johkoh T, Sakai F, Homma S; Diffuse Lung Diseases Research Group of the Ministry of Health, Labour and Welfare, Japan. Sakamoto S, et al. Among authors: sasaki s. Eur Respir J. 2021 Jan 5;57(1):2000348. doi: 10.1183/13993003.00348-2020. Print 2021 Jan. Eur Respir J. 2021. PMID: 32703779 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,354 results

Search Page